S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AKTX Akari Therapeutics PLC

2.45

0.02 (0.82%)

09 Nov 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics PLC News

Form 8-K - Current report
Saturday 9 November 2024 (14 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Tuesday 15 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Saturday 12 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Thursday 10 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 5 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 3 October 2024 (1 month ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Monday 30 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 19 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 17 September 2024 (2 months ago) • Edgar (US Regulatory)

More Akari Therapeutics PLC News Articles

UBS Global Asset Managem...

Ubs Asset Management

M13 Ventures Iv

Gennx360 Capital Partner...

Mac Venture Capital Sele...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions